;PMID: 12147210
;source_file_2924.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..37] = [t:0..37]
;1)sentence:[e:43..201] = [t:43..201]
;2)section:[e:205..297] = [t:205..297]
;3)section:[e:301..356] = [t:301..356]
;4)sentence:[e:360..455] = [t:360..455]
;5)sentence:[e:456..501] = [t:456..501]
;6)sentence:[e:502..559] = [t:502..559]
;7)sentence:[e:560..727] = [t:560..727]
;8)sentence:[e:728..937] = [t:728..937]
;9)sentence:[e:938..1028] = [t:938..1028]
;10)sentence:[e:1029..1218] = [t:1029..1218]
;11)sentence:[e:1219..1326] = [t:1219..1326]
;12)sentence:[e:1327..1428] = [t:1327..1428]
;13)section:[e:1432..1477] = [t:1432..1477]

;section 0 Span:0..37
;Neuropeptides.  2002 Feb;36(1):13-21.
(SEC
  (FRAG (NNP:[0..13] Neuropeptides) (.:[13..14] .) (CD:[16..20] 2002)
        (CD:[21..27] Feb;36) (-LRB-:[27..28] -LRB-) (CD:[28..29] 1)
        (-RRB-:[29..30] -RRB-) (::[30..31] :) (NN:[31..34] 13-) (CD:[34..36] 21)
        (.:[36..37] .)))

;sentence 1 Span:43..201
;Differences in the expression of neurokinin receptor in neural and bone
;marrow  mesenchymal cells: implications for neuronal expansion from bone
;marrow cells.
;[76..95]:gene-protein:"neurokinin receptor"
(SENT
  (NP-HLN
    (NP
      (NP (NNS:[43..54] Differences))
      (PP (IN:[55..57] in)
        (NP
          (NP (DT:[58..61] the) (NN:[62..72] expression))
          (PP (IN:[73..75] of)
            (NP (NN:[76..86] neurokinin) (NN:[87..95] receptor)))
          (PP-LOC (IN:[96..98] in)
            (NP
              (NP (JJ:[99..105] neural)
                (NML-1 (-NONE-:[105..105] *P*)))
              (CC:[106..109] and)
              (NP
                (NML (NN:[110..114] bone) (NN:[115..121] marrow))
                (NML-1 (JJ:[123..134] mesenchymal) (NNS:[135..140] cells))))))))
    (::[140..141] :)
    (NP
      (NP (NNS:[142..154] implications))
      (PP (IN:[155..158] for)
        (NP
          (NP (JJ:[159..167] neuronal) (NN:[168..177] expansion))
          (PP (IN:[178..182] from)
            (NP
              (NML (NN:[183..187] bone) (NN:[188..194] marrow))
              (NNS:[195..200] cells))))))
    (.:[200..201] .)))

;section 2 Span:205..297
;Bandari PS, Qian J, Yehia G, Seegopaul HP, Harrison JS, Gascon P, Fernandes
;H,  Rameshwar P.
(SEC
  (FRAG (NNP:[205..212] Bandari) (NNP:[213..215] PS) (,:[215..216] ,)
        (NNP:[217..221] Qian) (NNP:[222..224] J,) (NNP:[225..230] Yehia)
        (NNP:[231..232] G) (,:[232..233] ,) (NNP:[234..243] Seegopaul)
        (NNP:[244..246] HP) (,:[246..247] ,) (NNP:[248..256] Harrison)
        (NNP:[257..259] JS) (,:[259..260] ,) (NNP:[261..267] Gascon)
        (NNP:[268..270] P,) (NNP:[271..280] Fernandes) (NNP:[281..283] H,)
        (NNP:[285..294] Rameshwar) (NNP:[295..297] P.)))

;section 3 Span:301..356
;UMDNJ-New Jersey Medical School, Newark, NJ 07103, USA.
(SEC
  (FRAG (NNP:[301..310] UMDNJ-New) (NNP:[311..317] Jersey)
        (NNP:[318..325] Medical) (NNP:[326..332] School) (,:[332..333] ,)
        (NNP:[334..340] Newark) (,:[340..341] ,) (NNP:[342..344] NJ)
        (CD:[345..350] 07103) (,:[350..351] ,) (NNP:[352..355] USA)
        (.:[355..356] .)))

;sentence 4 Span:360..455
;The neurokinin-1 (NK-1) receptor interacts with peptides that belong to the 
;tachykinin family.
;[364..376]...[384..392]:gene-protein:"neurokinin-1"..."receptor"
;[378..382]:gene-protein:"NK-1"
;[437..447]:gene-protein:"tachykinin"
(SENT
  (S
    (NP-SBJ (DT:[360..363] The)
      (NML
        (NML (NN:[364..376] neurokinin-1))
        (NML (-LRB-:[377..378] -LRB-) (NN:[378..382] NK-1)
             (-RRB-:[382..383] -RRB-)))
      (NN:[384..392] receptor))
    (VP (VBZ:[393..402] interacts)
      (PP-CLR (IN:[403..407] with)
        (NP
          (NP (NNS:[408..416] peptides))
          (SBAR
            (WHNP-1 (WDT:[417..421] that))
            (S
              (NP-SBJ-1 (-NONE-:[421..421] *T*))
              (VP (VBP:[422..428] belong)
                (PP (TO:[429..431] to)
                  (NP (DT:[432..435] the) (NN:[437..447] tachykinin)
                      (NN:[448..454] family)))))))))
    (.:[454..455] .)))

;sentence 5 Span:456..501
;NK-1 is inducible in bone marrow (BM) stroma.
;[456..460]:gene-protein:"NK-1"
(SENT
  (S
    (NP-SBJ (NN:[456..460] NK-1))
    (VP (VBZ:[461..463] is)
      (ADJP-PRD (JJ:[464..473] inducible)
        (PP (IN:[474..476] in)
          (NP
            (NML
              (NML (NN:[477..481] bone) (NN:[482..488] marrow))
              (NML (-LRB-:[489..490] -LRB-) (NN:[490..492] BM)
                   (-RRB-:[492..493] -RRB-)))
            (NN:[494..500] stroma)))))
    (.:[500..501] .)))

;sentence 6 Span:502..559
;In neural  cells, its expression is high to constitutive.
(SENT
  (S
    (PP-LOC (IN:[502..504] In)
      (NP (JJ:[505..511] neural) (NNS:[513..518] cells)))
    (,:[518..519] ,)
    (NP-SBJ (PRP$:[520..523] its) (NN:[524..534] expression))
    (VP (VBZ:[535..537] is)
      (ADJP-PRD (JJ:[538..542] high)
        (PP (TO:[543..545] to)
          (NP (JJ:[546..558] constitutive)))))
    (.:[558..559] .)))

;sentence 7 Span:560..727
;Screening of three cDNA libraries  indicated that this different in NK-1
;expression in neural and BM cells could  not be explained by differences in
;the cDNA sequence.
;[628..632]:gene-protein:"NK-1"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[560..569] Screening))
      (PP (IN:[570..572] of)
        (NP (CD:[573..578] three) (NN:[579..583] cDNA)
            (NNS:[584..593] libraries))))
    (VP (VBD:[595..604] indicated)
      (SBAR (IN:[605..609] that)
        (S
          (NP-SBJ-2
            (NP (DT:[610..614] this) (JJ:[615..624] different))
            (PP (IN:[625..627] in)
              (NP
                (NP (NN:[628..632] NK-1) (NN:[633..643] expression))
                (PP (IN:[644..646] in)
                  (NP
                    (NP (JJ:[647..653] neural)
                      (NML-1 (-NONE-:[653..653] *P*)))
                    (CC:[654..657] and)
                    (NP (NN:[658..660] BM)
                      (NML-1 (NNS:[661..666] cells))))))))
          (VP (MD:[667..672] could) (RB:[674..677] not)
            (VP (VB:[678..680] be)
              (VP (VBN:[681..690] explained)
                (NP-2 (-NONE-:[690..690] *))
                (PP (IN:[691..693] by)
                  (NP
                    (NP (NNS:[694..705] differences))
                    (PP (IN:[706..708] in)
                      (NP (DT:[709..712] the) (NN:[713..717] cDNA)
                          (NN:[718..726] sequence)))))))))))
    (.:[726..727] .)))

;sentence 8 Span:728..937
;Analyses the 5' flanking  sequence in BM stroma and three neural cell lines
;indicated that sequence  +1/+358 relative to the transcription start (TS)
;site could account for the  differences in NK-1 expression.
;[921..925]:gene-protein:"NK-1"
(SENT
  (S
    (NP-SBJ
      (NP (NNS:[728..736] Analyses))
      (NP
        (NP
          (NP (DT:[737..740] the)
            (NML (CD:[741..742] 5) (SYM:[742..743] '))
            (NN:[744..752] flanking) (NN:[754..762] sequence))
          (PP (IN:[763..765] in)
            (NP (NN:[766..768] BM) (NN:[769..775] stroma))))
        (CC:[776..779] and)
        (NP (CD:[780..785] three) (JJ:[786..792] neural) (NN:[793..797] cell)
            (NNS:[798..803] lines))))
    (VP (VBD:[804..813] indicated)
      (SBAR (IN:[814..818] that)
        (S
          (NP-SBJ
            (NP (NN:[819..827] sequence) (SYM:[829..830] +) (CD:[830..831] 1)
                (SYM:[831..832] /) (SYM:[832..833] +) (CD:[833..836] 358))
            (ADJP (JJ:[837..845] relative)
              (PP (TO:[846..848] to)
                (NP (DT:[849..852] the)
                  (NML
                    (NML (NN:[853..866] transcription) (NN:[867..872] start))
                    (NML (-LRB-:[873..874] -LRB-) (NN:[874..876] TS)
                         (-RRB-:[876..877] -RRB-)))
                  (NN:[878..882] site)))))
          (VP (MD:[883..888] could)
            (VP (VB:[889..896] account)
              (PP (IN:[897..900] for)
                (NP
                  (NP (DT:[901..904] the) (NNS:[906..917] differences))
                  (PP (IN:[918..920] in)
                    (NP (NN:[921..925] NK-1) (NN:[926..936] expression))))))))))
    (.:[936..937] .)))

;sentence 9 Span:938..1028
;Particular cytokines could reverse the  repressive effects of region +1/+358
;in BM stroma.
;[949..958]:gene-protein:"cytokines"
(SENT
  (S
    (NP-SBJ (JJ:[938..948] Particular) (NNS:[949..958] cytokines))
    (VP (MD:[959..964] could)
      (VP (VB:[965..972] reverse)
        (NP
          (NP (DT:[973..976] the) (JJ:[978..988] repressive)
              (NNS:[989..996] effects))
          (PP (IN:[997..999] of)
            (NP (NN:[1000..1006] region) (SYM:[1007..1008] +)
                (CD:[1008..1009] 1) (SYM:[1009..1010] /) (SYM:[1010..1011] +)
                (CD:[1011..1014] 358))))
        (PP (IN:[1015..1017] in)
          (NP (NN:[1018..1020] BM) (NN:[1021..1027] stroma)))))
    (.:[1027..1028] .)))

;sentence 10 Span:1029..1218
;The effects of NF-kappa B and  cAMP activators were studied in stromal cells
;using a dominant negative  inhibitor of NF-kappa B (I kappa B) or a repressor
;of CRE activators (ICERII  gamma).
;[1044..1054]:gene-protein:"NF-kappa B"
;[1146..1156]:gene-protein:"NF-kappa B"
;[1158..1167]:gene-protein:"I kappa B"
;[1187..1190]:gene-protein:"CRE"
;[1203..1216]:gene-protein:"ICERII  gamma"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[1029..1032] The) (NNS:[1033..1040] effects))
      (PP (IN:[1041..1043] of)
        (NP
          (NP (NN:[1044..1052] NF-kappa) (NN:[1053..1054] B))
          (CC:[1055..1058] and)
          (NP (NN:[1060..1064] cAMP) (NNS:[1065..1075] activators)))))
    (VP (VBD:[1076..1080] were)
      (VP (VBN:[1081..1088] studied)
        (NP-1 (-NONE-:[1088..1088] *))
        (PP-LOC (IN:[1089..1091] in)
          (NP (JJ:[1092..1099] stromal) (NNS:[1100..1105] cells)))
        (S-MNR
          (NP-SBJ (-NONE-:[1105..1105] *))
          (VP (VBG:[1106..1111] using)
            (NP
              (NP
                (NP (DT:[1112..1113] a) (JJ:[1114..1122] dominant)
                    (JJ:[1123..1131] negative) (NN:[1133..1142] inhibitor))
                (PP (IN:[1143..1145] of)
                  (NP (NN:[1146..1154] NF-kappa) (NN:[1155..1156] B)))
                (PRN (-LRB-:[1157..1158] -LRB-)
                  (NP
                    (NP (NN:[1158..1159] I))
                    (PP (SYM:[1160..1165] kappa)
                      (NP (NN:[1166..1167] B))))
                  (-RRB-:[1167..1168] -RRB-)))
              (CC:[1169..1171] or)
              (NP
                (NP (DT:[1172..1173] a) (NN:[1174..1183] repressor))
                (PP (IN:[1184..1186] of)
                  (NP (NN:[1187..1190] CRE) (NNS:[1191..1201] activators)
                    (PRN (-LRB-:[1202..1203] -LRB-)
                      (NP (NN:[1203..1209] ICERII) (SYM:[1211..1216] gamma))
                      (-RRB-:[1216..1217] -RRB-))))))))))
    (.:[1217..1218] .)))

;sentence 11 Span:1219..1326
;The results showed that their effects of these transcription factors 
;depended on the stimulating cytokine.
(SENT
  (S
    (NP-SBJ (DT:[1219..1222] The) (NNS:[1223..1230] results))
    (VP (VBD:[1231..1237] showed)
      (SBAR (IN:[1238..1242] that)
        (S
          (NP-SBJ
            (NP (PRP$:[1243..1248] their) (NNS:[1249..1256] effects))
            (PP (IN:[1257..1259] of)
              (NP (DT:[1260..1265] these) (NN:[1266..1279] transcription)
                  (NNS:[1280..1287] factors))))
          (VP (VBD:[1289..1297] depended)
            (PP (IN:[1298..1300] on)
              (NP (DT:[1301..1304] the) (VBG:[1305..1316] stimulating)
                  (NN:[1317..1325] cytokine)))))))
    (.:[1325..1326] .)))

;sentence 12 Span:1327..1428
;This study provides insight into the  tissue-specific differences in the
;expression of the NK-1 gene.
;[1418..1422]:gene-rna:"NK-1"
(SENT
  (S
    (NP-SBJ (DT:[1327..1331] This) (NN:[1332..1337] study))
    (VP (VBZ:[1338..1346] provides)
      (NP
        (NP (NN:[1347..1354] insight))
        (PP (IN:[1355..1359] into)
          (NP
            (NP (DT:[1360..1363] the)
              (ADJP (NN:[1365..1371] tissue) (HYPH:[1371..1372] -)
                    (JJ:[1372..1380] specific))
              (NNS:[1381..1392] differences))
            (PP (IN:[1393..1395] in)
              (NP
                (NP (DT:[1396..1399] the) (NN:[1400..1410] expression))
                (PP (IN:[1411..1413] of)
                  (NP (DT:[1414..1417] the) (NN:[1418..1422] NK-1)
                      (NN:[1423..1427] gene)))))))))
    (.:[1427..1428] .)))

;section 13 Span:1432..1477
;PMID: 12147210 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1432..1436] PMID) (::[1436..1437] :) (CD:[1438..1446] 12147210)
        (NN:[1447..1448] -LSB-) (NNP:[1448..1454] PubMed) (::[1455..1456] -)
        (NN:[1457..1464] indexed) (IN:[1465..1468] for)
        (NNP:[1469..1477] MEDLINE-RSB-)))
